asco.org3 天
About ASCO
Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
asco.org5 天
Choosing Wisely
The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...
asco.org6 天
Training Programs
ASCO educational meetings and workshops bring together experts in the field in small, intensive-learning settings to provide attendees with in-depth, case-based training. The ever-expanding roster of ...
asco.org3 天
Current practices and attitudes in menstrual management in adolescents with cancer: A ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
START2: Tecemotide in unresectable stage III NSCLC after first-line concurrent ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Performance of mutation risk prediction models in a racially diverse multi-gene panel ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Phase 3 study of durvalumab combined with oleclumab or monalizumab in patients with ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Phase 1/2 study of the selective TRK inhibitor larotrectinib in pediatric patients with cancer.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Activity and safety of larotrectinib in adult patients with TRK fusion cancer: An expanded ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3 天
Safety, pharmacokinetics (PK), and clinical efficacy of ICP-723, a highly selective next ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...